Filing Details
- Accession Number:
- 0001209191-21-017543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:39:03
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 20:39:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422995 | J. Markus Cappel | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Bus. Officer & Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-01 | 5,417 | $6.62 | 91,243 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 11,667 | $10.86 | 102,910 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 16,008 | $11.02 | 118,918 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 7,053 | $67.68 | 111,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-01 | 20,680 | $68.51 | 91,185 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-01 | 5,359 | $69.09 | 85,826 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 5,417 | $0.00 | 5,417 | $6.62 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 11,667 | $0.00 | 11,667 | $10.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 16,008 | $0.00 | 16,008 | $11.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,958 | 2027-02-28 | No | 4 | M | Direct | |
| 24,792 | 2028-03-05 | No | 4 | M | Direct | |
| 42,292 | 2029-03-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $66.99 to $67.98 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $68.00 to $68.98 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $69.00 to $69.24 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of March 1, 2021, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
